This website is intended for healthcare professionals

Menopause

Contraception consultation and assessment for women over 40

Discussing contraception can be an emotive issue for certain patient groups, and health professionals need to be supportive of women's personal and religious beliefs, and mindful of the terminology...

Compounded bioidentical HRT improves quality of life and reduces menopausal symptoms

The mean age of women (n=69) aged 37 to 64 was 52 (±5.4 SD) years. Follow-up time was from 6–24 months with a median follow-up time of 11 months (±6.0 SD)..

Contraception for women aged 40 and over

Menopause is defined as the last menstrual period (LMP); a diagnosis which can only be made retrospectively following one year of amenorrhoea or 2 years if under 50. The diagnosis is usually made...

Hormone replacement therapy: update and practical prescribing

Symptoms are experienced by around 70-80% of women during the perimenopause and menopause (O’Neill and Eden, 2012). The symptoms are varied and include vasomotor symptoms, such as flushing and night...

Understanding bioidentical hormones and their effect on quality of life

Hormones play a huge role in a patient's quality of life and when they become imbalanced, the effects can be wide-ranging. Imbalances can develop as a result of endogenous or exogenous change, leading...

Why choose Journal of Prescribing Practice?

Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.

What's included

  • Evidence-based best practice

  • Drug updates

  • Pharmacology information

  • Calculation skills

Subscriptions start:

From £16.25 GBP